| 标题 |
1494P Pooled efficacy and safety outcomes with tremelimumab plus durvalumab in participants (pts) with unresectable hepatocellular carcinoma (uHCC) from the combined China extension and global cohorts in the phase III HIMALAYA study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:B. Sangro; S. Qin; R.K. Kelley; W. Wang; S.L. Chan; et al 出版日期:2025-11-06 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)